Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular diseaseJUHAN-VAGUE, I; VAGUE, P.American journal of obstetrics and gynecology. 1990, Vol 163, Num 1, pp 313-315, issn 0002-9378, 3 p., . 2Article

Principles for the design of rheological studies in diabetes mellitusVAGUE, P; JUHAN-VAGUE, I.Clinical hemorheology. 1987, Vol 7, Num 4, pp 637-647, issn 0271-5198Article

Hypofibrinolysis and insulin-resistanceJUHAN-VAGUE, I; VAGUE, P.Diabète et métabolisme (Paris). 1991, Vol 17, Num 1BIS, pp 96-100, issn 0338-1684, 5 p.Conference Paper

Diabète et fibrinolyse = Diabetes and fibrinolysisJUHAN-VAGUE, I; VAGUE, P.Revue française d'endocrinologie clinique, nutrition et métabolisme. 1990, Vol 31, Num 2, pp 121-129, issn 0048-8062, 9 p.Article

Increased plasma plasminogen activator inhibitor 1 levels. A possible link betwwen insulin resistance and atherothrombosisJUHAN-VAGUE, I; ALESSI, M. C; VAGUE, P et al.Diabetologia (Berlin). 1991, Vol 34, Num 7, pp 457-462, issn 0012-186XArticle

L'hypofibrinolyse est-elle un facteru de risque de thrombose? = Defective fibrinolysis: risk factor of venous thrombosisJUHAN-VAGUE, I.La Revue du praticien (Paris). 1989, Vol 39, Num 26, pp 2337-2339, issn 0035-2640Article

Athérome et antithrombotiques = Atheroma and antithromboticsJUHAN-VAGUE, I.Archives des maladies du coeur et des vaisseaux. 1992, Vol 85, pp 171-173, issn 0003-9683, NS2Conference Paper

Dyslipidémies, hypolipidémiants et thrombose = Dyslipidaemia, lipid lowering drugs and thrombosisAMBROSI, P; JUHAN-VAGUE, I.Archives des maladies du coeur et des vaisseaux. 1995, Vol 88, Num 11, pp 1641-1645, issn 0003-9683Conference Paper

Les traitements fibrinolytiques = Fibrinolytic treatmentsBORY, M; JUHAN-VAGUE, I.Méditerranée médicale. 1985, Vol 13, Num 345, pp 35-43, issn 0302-9263Article

For the recuperation of the process of change for the people and with the people : Reform and revolution in South America: a forum on Bolivia and Venezuela = Pour la récupération du processus de changement, pour les gens et avec les gens : La réforme et la révolution en Amérique du Sud : un forum sur la Bolivie et le VenezuelaDialectical anthropology. 2011, Vol 35, Num 3, pp 285-293, issn 0304-4092, 9 p.Article

Formation, inhibition and clearance of plasmin in vivoCHANDLER, W. L; ALESSI, M. C; AILLAUD, M. F et al.Haemostasis. 2000, Vol 30, Num 4, pp 204-218, issn 0301-0147Article

Abnormalities of erythrocyte membrane lipids in insulin-dependent diabetics are improved by short term strict control of diabetesJUHAN-VAGUE, I; DRISS, F; ROUL, C et al.Clinical hemorheology. 1984, Vol 4, Num 5, pp 455-459, issn 0271-5198Article

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitusJUHAN-VAGUE, I; ALESSI, M. C; VAGUE, P et al.Annals of medicine (Helsinki). 1996, Vol 28, Num 4, pp 371-380, issn 0785-3890Conference Paper

Hemobiology, vascular disease, and diabetes with special reference to impaired fibrinolysisVAGUE, P; RACCAH, D; JUHAN-VAGUE, I et al.Metabolism, clinical and experimental. 1992, Vol 41, Num 5, pp 2-6, issn 0026-0495, SUP1Conference Paper

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese womenVAGUE, P; JUHAN-VAGUE, I; CHABERT, V et al.Metabolism, clinical and experimental. 1989, Vol 38, Num 9, pp 913-915, issn 0026-0495Article

Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjectsVAGUE, P; JUHAN-VAGUE, I; ALESSI, M. C et al.Thrombosis and haemostasis. 1987, Vol 57, Num 3, pp 326-328, issn 0340-6245Article

The fibrinolytic system and obesityLIJNEN, H. R; JUHAN-VAGUE, I.Thrombosis and haemostasis. 2002, Vol 88, Num 5, issn 0340-6245, p. 882Article

Involvement of the hemostatic system in the insulin resistance syndrome : a study of 1500 patients with angina pectorisJUHAN-VAGUE, I; THOMPSON, S. G; JESPERSEN, J et al.Arteriosclerosis and thrombosis. 1993, Vol 13, Num 12, pp 1865-1873, issn 1049-8834Article

Endothélium, thrombose et fibrinolyse : Endothélium = Endothelium, thrombosis and fibrinolyses : EndotheliumALESSI, M.-C; JUHAN-VAGUE, I.La Revue du praticien (Paris). 1997, Vol 47, Num 20, pp 2227-2231, issn 0035-2640Article

Haemostatic parameters and vascular riskJUHAN-VAGUE, I.Atherosclerosis. 1996, Vol 124, pp S49-S55, issn 0021-9150, SUPConference Paper

De la contribution des ententes et des concentrations à l'assainissement économiqueVAGUE, M.Revue du marché commun. 1994, Num 383, pp 659-664, issn 0035-2616Article

Naît-on ou devient-on obèse? = Obesity: is it congenital or catchedVAGUE, J.Gazette médicale de France (1969). 1984, Vol 91, Num 11, pp 53-61, issn 0016-5557, 5 p.Article

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseasesMAVRI, A; ALESSI, M.-C; JUHAN-VAGUE, I et al.Journal of internal medicine. 2004, Vol 255, Num 4, pp 448-456, issn 0954-6820, 9 p.Article

Desmopressine et fibrinolyse = Desmopressin and fibrinolysisJUHAN-VAGUE, I.STV. Sang thrombose vaisseaux. 1995, Vol 7, Num AVR, pp 18-21, issn 0999-7385, NSConference Paper

Vieillissement de la paroi artérielle : endothélium, thrombose et fibrinolyse = Ageing of the artery wall. Endothelium, thrombosis and fibrinolysisJUHAN-VAGUE, I; ALESSI, M. C.Annales de cardiologie et d'angéiologie (Paris). 1991, Vol 40, Num 5, pp 243-247, issn 0003-3928, 5 p.Conference Paper